No Detail Found!

Serological studies of influenza infection among population in southern region of Kazakhstan during the 2018-2021 epidemic season

Author(s)
Mira Galautdinovna Shamenova The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Tatyana Ivanovna Glebova The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Nailya Galiveyevna Klivleyeva The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Sagadat Bakhytkyzy Baiseiit The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Asem Maratovna Baimukhametova The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Nurbol Temirbayevich Saktaganov The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Nuray Syrlybayevna Ongarbayeva The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Dariya Azamatovna Ismagulova The Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan.
Abstract
Objective: To conduct serological studies of inuflenza infection rate during an epidemic. Methods: The retrospective study was conducted at the Research and Production Centre for Microbiology and Virology, Almaty, Kazakhstan, and comprised data, including blood samples, from patients with symptoms of acute respiratory viral infection, bronchitis and pneumonia during 2018-21 from various healthcare institutions in the Almaty region. Serological tests on blood serums were carried out sing haem agglutination inhibition assay and enzyme-linked immunosorbent assay. Data was analysed using Graph Pad Prism 9. Results: Of the 779 blood samples, 392(50.3%) came from women and 387(49.7%) from men. The overall age range was 080 years. Serological analyses using haem agglutination inhibition assay showed the presence of anti-hemagglutinins against pandemic A(H1N1)pdm09 virus in 292(37.5%) samples, inuflenza A/H3N2 virus in 340(43.6%) and type B virus in 53(6.8%). Antibodies against two subtypes of inuflenza A virus and type B virus were simultaneously identiefid in 25(3.2%) cases, whereas against inuflenza A (H1N1+H3N2) viruses in 69(8.9%). In enzyme-linked immunosorbent assay, antibodies against inuflenza A/H1N1pdm virus were detected in 108(13.9%) cases, against A/H3N2 virus in 105(13.5%) and type B virus in 65(8.3%). Antibodies simultaneously against two subtypes of inuflenza A virus were identiefid in 46(5.9%) of blood serums, and against inuflenza A and B viruses in 60(7.7%). Conclusion: Co-circulation of inuflenza A and B viruses was observed, conrfiming the role of inuflenza viruses in the epidemic process.
Publication Details
Page(s) 804-807
Published Journal: Journal of Pakistan Medical Association, Volume: 73, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Antigen, Virus, serum, Influenza, Diagnosis.
0

Citations

0

Downloads

49

Views